Suda Kenji, Raboisson Marie-Josée, Piette Eric, Dahdah Nagib S, Miró Joaquim
Division of Pediatric Cardiology, Department of Pediatrics, Tenri Hospital, Tenri, Japan.
J Am Coll Cardiol. 2004 May 5;43(9):1677-82. doi: 10.1016/j.jacc.2003.12.042.
We sought to determine the incidence, nature, and predisposing factors of atrioventricular block (AVB) associated with closure of atrial septal defects (ASDs) using the Amplatzer septal occluder (ASO).
In our institution, 162 patients underwent ASD closure using ASO between December 1997 and December 2001. This includes small children with large defects.
Electrocardiographic tracings during ASO implantation and at follow-up visits were reviewed. Anatomic characteristics and device size were assessed as potential risk factors for AVB.
Ten patients (6.2%) presented with new-onset (n = 9) or aggravation of preexisting (n = 1) AVB. Atrioventricular block occurred during the procedure (n = 3) or was first noted one day to one week later (n = 7). Patients had first-degree (n = 4), second-degree Wenckebach (n = 4), or third-degree (n = 2) AVB, with no symptoms or hemodynamic compromise. First-degree AVB persisted in two patients at 12 and 33 months of follow-up, whereas most recovered normal AV conduction within one (n = 7) or six months (n = 1). A larger shunt (Qp/Qs ratio 2.8 +/- 0.9 vs. 2.1 +/- 0.8, p < 0.01) and device size (24 +/- 5 vs. 19 +/- 6 mm, p < 0.01) were the only determinant factors for AVB. A device size > or =19 mm was used in 90% (9 of 10) of patients who developed AVB, as compared with 49% of those without AVB (p < 0.02).
Closure of ASDs using the large ASO can be associated with the development of AV block and mandate a closer follow-up. In our series, however, all AVBs resolved or improved spontaneously, with no recurrence at mid-term follow-up.
我们试图确定使用Amplatzer房间隔封堵器(ASO)关闭房间隔缺损(ASD)相关的房室传导阻滞(AVB)的发生率、性质和诱发因素。
在我们机构,1997年12月至2001年12月期间,162例患者使用ASO进行了ASD封堵。这包括患有大缺损的小儿患者。
回顾了ASO植入期间及随访时的心电图记录。评估解剖特征和封堵器尺寸作为AVB的潜在危险因素。
10例患者(6.2%)出现新发(n = 9)或原有AVB加重(n = 1)。房室传导阻滞发生在手术过程中(n = 3)或在术后1天至1周首次发现(n = 7)。患者出现一度(n = 4)、二度文氏阻滞(n = 4)或三度(n = 2)AVB,无任何症状或血流动力学损害。随访12个月和33个月时,2例患者一度AVB持续存在,而大多数患者在1个月(n = 7)或6个月(n = 1)内恢复正常房室传导。较大的分流(Qp/Qs比值2.8±0.9对2.1±0.8,p < 0.01)和封堵器尺寸(24±5对19±6 mm,p < 0.01)是AVB的唯一决定因素。发生AVB的患者中90%(10例中的9例)使用了尺寸≥19 mm的封堵器,而未发生AVB的患者中这一比例为49%(p < 0.02)。
使用大型ASO关闭ASD可能与房室传导阻滞发生有关,需要密切随访。然而,在我们的系列研究中,所有AVB均自发缓解或改善,中期随访无复发。